Latest by Mark Harrington
Introducing the 2014 Pipeline Report on HIV, Hepatitis C Virus (HCV) and Tuberculosis (TB)
Last year we wrote:
[Getting] the best drugs to the most people as quickly as possible ... requires that the compounds and combination products be:
Discovered and developed in a high-quality research program; Approved by a national or multinati...
The White House's Fuzzy Math
On World AIDS Day, December 1, 2013, the White House Office of National AIDS Policy (ONAP) issued a peppy and upbeat status report on the National HIV/AIDS Strategy (NHAS), claiming progress on eight of nine outcome indicators. Yet when reviewed in t...
From Sky High to CHAI: What Needs to Be Done About Dolutegravir Pricing?
With a low 50 mg once-daily dose, good efficacy, minimal toxicity, pregnancy category B, and the potential to be low cost and co-formulated, dolutegravir is an attractive contender for use in low- and middle-income countries.
Swiftly after the FDA a...
Razing the House of Cards: The Discovery of HAART and the Push for Evidence-Based HIV Treatment
This is the third in a series looking back at the first two decades of TAG's work to speed up AIDS research. In Part I: TAG's early campaigns to reform the National Institutes of Health (NIH) AIDS research, boost the federal budget, and revitalize HI...
What We Need to Cure AIDS?
A cure for HIV is possible: one man, the so-called Berlin patient, has already been cured of chronic HIV infection with an immune system transplant with cells genetically resistant to HIV. After four years, the man remains free of detectable HIV, and...
World Health Organization HIV Treatment Guidelines Evolve
Unusually, there was something to celebrate on World AIDS Day in 2009, even if it was only on paper. The World Health Organization (WHO) updated its antiretroviral treatment (ART) guidelines for adults, adolescents, pregnant women, mother-to-child tr...
16 Radical Steps to End the AIDS Epidemic
From a special plenary session titled "Looking to the Future -- The Epidemic Steps to End the Epidemic in 2031, and New Directions in AIDS Research" at the XVII International AIDS Conference in Mexico City, August 6, 2008.
Mark HarringtonTwenty year...
AIDS Activism, Boehringer Ingelheim and the Broken Social Contract
Sheraton Golf Parco de'Medici, 6 April 2006, Rome
[Note: This is a revised and expanded version of remarks I gave yesterday at the Boehringer Ingelheim symposium on HIV past and future. The two-day symposium is taking place at a business-style 'h...
Comments on Problems in the Current Draft World Health Organization (WHO) Antiretroviral Treatment Guidelines for Resource Limited Settings
Twenty-one years into the HIV pandemic the World Health Organization (WHO) has loosened itself from its slothlike lethargy and bureaucratic torpor to produce, seemingly with great reluctance and certainly with great confusion, a draft document on "An...